Rich Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages on developing innovative therapies in oncology. It develops RP-323 for the treatment of Hodgkin’s lymphoma, Acute Myelogenous Leukemia, and to cause elevation of white blood cells in patients depleted of these elements due to various conditions. The company was founded on August 9, 2010 and is headquartered in Beverly Hills, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Rich Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Rich Pharmaceuticals Inc market cap is $941,900.00.
What is the 52-week high for Rich Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Rich Pharmaceuticals Inc 52 week high is $0.0046 as of October 10, 2025.
What is the 52-week low for Rich Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Rich Pharmaceuticals Inc 52 week low is $0.00 as of October 10, 2025.
What is Rich Pharmaceuticals Inc stock price today?
Rich Pharmaceuticals Inc stock price today is $0.0005.
What was Rich Pharmaceuticals Inc stock price yesterday?
Rich Pharmaceuticals Inc stock price yesterday was $0.0005.
What is the 50-day moving average of Rich Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Rich Pharmaceuticals Inc 50-day moving average is $0.0004.